HealthStream (NASDAQ:HSTM) Announces Earnings Results

HealthStream (NASDAQ:HSTM) issued its earnings results on Monday. The technology company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02, FiscalAI reports. The business had revenue of $83.31 million for the quarter, compared to analysts’ expectations of $82.24 million. HealthStream had a net margin of 6.60% and a return on equity of 6.81%.

HealthStream Trading Up 2.6%

Shares of HealthStream stock traded up $0.88 during trading on Monday, hitting $34.58. The stock had a trading volume of 281,916 shares, compared to its average volume of 250,824. The firm has a market cap of $1.01 billion, a price-to-earnings ratio of 48.03, a P/E/G ratio of 3.90 and a beta of 0.45. HealthStream has a 12 month low of $19.50 and a 12 month high of $35.60. The business’s 50-day moving average is $30.94 and its 200 day moving average is $25.59.

Insider Buying and Selling at HealthStream

In other HealthStream news, CEO Robert A. Frist, Jr. sold 144,068 shares of the company’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $29.50, for a total value of $4,250,006.00. Following the transaction, the chief executive officer directly owned 3,907,038 shares in the company, valued at $115,257,621. This represents a 3.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Linda Rebrovick sold 12,000 shares of the firm’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $35.00, for a total value of $420,000.00. Following the completion of the sale, the director directly owned 39,329 shares in the company, valued at approximately $1,376,515. The trade was a 23.38% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 20.40% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on HSTM. Wall Street Zen upgraded HealthStream from a “hold” rating to a “buy” rating in a research report on Saturday. Freedom Capital raised HealthStream to a “hold” rating in a report on Tuesday, October 13th. Canaccord Genuity Group raised their target price on HealthStream from $24.00 to $27.00 and gave the stock a “hold” rating in a research note on Tuesday, July 21st. Weiss Ratings upgraded HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Finally, Citigroup reaffirmed a “market perform” rating on shares of HealthStream in a report on Tuesday, October 27th. One investment analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $27.00.

About HealthStream

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.